BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23149477)

  • 1. Factors predictive of medication nonadherence after renal transplantation: a French observational study.
    Couzi L; Moulin B; Morin MP; Albano L; Godin M; Barrou B; Alamartine E; Morelon E; Girardot-Seguin S; Mendes L; Misdrahi D; Cassuto E; Merville P
    Transplantation; 2013 Jan; 95(2):326-32. PubMed ID: 23149477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rurality and other factors associated with adherence to immunosuppressant medications in community-dwelling solid-organ transplant recipients.
    Sankaranarayanan J; Collier D; Furasek A; Reardon T; Smith LM; McCartan M; Langnas AN
    Res Social Adm Pharm; 2012; 8(3):228-39. PubMed ID: 21856247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Satisfaction and adherence with immunosuppressant treatment in renal transplant patients living with a working graft.
    Ortega F; Otero A; Crespo JF; Delgado JF; Borro JM; Cuervo J;
    J Nephrol; 2013; 26(2):297-305. PubMed ID: 22684646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of adherence to immunosuppressive drugs in kidney transplantation by control of medication dispensing.
    Brahm MM; Manfro RC; Mello D; Cioato S; Gonçalves LF
    Transplant Proc; 2012 Oct; 44(8):2391-3. PubMed ID: 23026602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of intention to adhere, beliefs and satisfaction about medicines on adherence in solid organ transplant recipients.
    Hugon A; Roustit M; Lehmann A; Saint-Raymond C; Borrel E; Hilleret MN; Malvezzi P; Bedouch P; Pansu P; Allenet B
    Transplantation; 2014 Jul; 98(2):222-8. PubMed ID: 24926826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrepancies between beliefs and behavior: a prospective study into immunosuppressive medication adherence after kidney transplantation.
    Massey EK; Tielen M; Laging M; Timman R; Beck DK; Khemai R; van Gelder T; Weimar W
    Transplantation; 2015 Feb; 99(2):375-80. PubMed ID: 25606787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretransplant Psychosocial Risk Factors May Not Predict Late Nonadherence and Graft Rejection in Adult Liver Transplant Recipients.
    Lieber SR; Helcer J; Leven E; Knight CS; Wlodarkiewicz C; Shenoy A; Shemesh E; Florman SS; Schiano TD; Annunziato RA
    Exp Clin Transplant; 2018 Oct; 16(5):533-540. PubMed ID: 28969524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Psychoeducational Intervention on Allograft Function in Kidney Transplant Patients: 10-Year Results of a Prospective Randomized Study.
    Breu-Dejean N; Driot D; Dupouy J; Lapeyre-Mestre M; Rostaing L
    Exp Clin Transplant; 2016 Feb; 14(1):38-44. PubMed ID: 26862823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients.
    Lim WH; Chadban SJ; Campbell S; Dent H; Russ GR; McDonald SP
    Nephrology (Carlton); 2010 Apr; 15(3):368-76. PubMed ID: 20470309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential adherence to immunosuppressive over nonimmunosuppressive medications in kidney transplant recipients.
    Terebelo S; Markell M
    Transplant Proc; 2010 Nov; 42(9):3578-85. PubMed ID: 21094819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reported Nonadherence to Immunosuppressive Medication in Young Adults After Heart Transplantation: A Retrospective Analysis of a National Registry.
    Tumin D; McConnell PI; Galantowicz M; Tobias JD; Hayes D
    Transplantation; 2017 Feb; 101(2):421-429. PubMed ID: 26950728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and outcomes of renal transplantation in elderly recipients.
    Nanmoku K; Matsuda Y; Yamamoto T; Tsujita M; Hiramitsu T; Goto N; Katayama A; Watarai Y; Kobayashi T; Uchida K
    Transplant Proc; 2012 Jan; 44(1):281-3. PubMed ID: 22310633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intentional and unintentional treatment nonadherence in patients with systemic lupus erythematosus.
    Daleboudt GM; Broadbent E; McQueen F; Kaptein AA
    Arthritis Care Res (Hoboken); 2011 Mar; 63(3):342-50. PubMed ID: 21120967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic association of FOXP3 gene polymorphisms with allograft rejection in renal transplant patients.
    Qiu XY; Jiao Z; Zhang M; Chen JP; Shi XJ; Zhong MK
    Nephrology (Carlton); 2012 May; 17(4):423-30. PubMed ID: 22239151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication misuse, nonadherence, and clinical outcomes among liver transplant recipients.
    Serper M; Patzer RE; Reese PP; Przytula K; Koval R; Ladner DP; Levitsky J; Abecassis MM; Wolf MS
    Liver Transpl; 2015 Jan; 21(1):22-8. PubMed ID: 25312406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of goal cognitions, illness perceptions and treatment beliefs in self-reported adherence after kidney transplantation: a cohort study.
    Massey EK; Tielen M; Laging M; Beck DK; Khemai R; van Gelder T; Weimar W
    J Psychosom Res; 2013 Sep; 75(3):229-34. PubMed ID: 23972411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of early corticosteroid withdrawal on graft survival in liver transplant recipients.
    Meadows HB; Taber DJ; Pilch NA; Tischer SM; Baliga PK; Chavin KD
    Transplant Proc; 2012 Jun; 44(5):1323-8. PubMed ID: 22664009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney transplantation in the US: an analysis of the OPTN/UNOS registry.
    Freitas MC
    Clin Transpl; 2011; ():1-16. PubMed ID: 22755397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to immunosuppression in adult lung transplant recipients: prevalence and risk factors.
    Bosma OH; Vermeulen KM; Verschuuren EA; Erasmus ME; van der Bij W
    J Heart Lung Transplant; 2011 Nov; 30(11):1275-80. PubMed ID: 21724418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Better actual 10-year renal transplant outcomes of 80% reduced cyclosporine exposure with sirolimus base therapy compared with full cyclosporine exposure without or with concomittant sirolimus treatment.
    Pliszczynski J; Kahan BD
    Transplant Proc; 2011 Dec; 43(10):3657-68. PubMed ID: 22172822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.